Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases

Archives of Surgery

Volumn 143, Issue 10, 2008, Pages 978-982

  Capussotti, Lorenzo ^a   Muratore, Andrea ^a   Baracchi, Filippo ^b   Lelong, Bernard ^b   Ferrero, Alessandro ^a   Regge, Daniele ^a   Delpero, Jean Robert ^b  

^a CANDIOLO CANCER INSTITUTE   (Italy)

^b INSTITUT PAOLI CALMETTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; IRINOTECAN; OXALIPLATIN;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; CLINICAL ARTICLE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER METASTASIS; LIVER RESECTION; LIVER WEIGHT; MALE; METASTASIS; OUTCOME ASSESSMENT; PORTAL VEIN; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; TUMOR VOLUME; VEIN LIGATION; VOLUMETRY;

ADULT; COHORT STUDIES; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; EMBOLIZATION, THERAPEUTIC; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIGATION; LIVER NEOPLASMS; LIVER REGENERATION; MALE; MIDDLE AGED; NEOPLASM STAGING; ORGAN SIZE; PORTAL VEIN; PREOPERATIVE CARE; PROBABILITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 54349110568     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.143.10.978     Document Type: Article

References (22)

1. Minagawa M, Makuuchi M, Torzilli G, et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg. 2000;231(4):487-499.
2. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230(3):309-321.
3. Giacchetti S, Itzhaki M, Gruia G, et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol. 1999;10 (6):663-669.
4. Capussotti L, Muratore A, Mulas MM, Massucco P, Aglietta M. Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases. Br J Surg. 2006;93(8):1001-1006.
5. Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol. 2006;24(13):2065-2072.
6. Yigitler C, Farges O, Kianmanesh R, Regimbeau JM, Abdalla EK, Belghiti K. The small remnant liver after major liver resection: how common and how relevant? Liver Transpl. 2003;9(9):S18-S25.
7. Karoui M, Penna C, Amin-Hashem M, et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg. 2006;243(1):1-7.
8. Khatri VP, Petrelli NJ, Belghiti J. Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? J Clin Oncol. 2005;23(33):8490-8499.
9. Denys AL, Abehsera M, Sauvanet A, Sibert A, Belghiti J, Menu Y. Failure of right portal vein ligation to induce left lobe hypertrophy due to intrahepatic portoportal collaterals: successful treatment with portal vein embolization. AJR Am J Roentgenol. 1999;173(3):633-635.
10. Broering DC, Hillert C, Krupski G, et al. Portal vein embolization vs portal vein ligation for induction of hypertrophy of the future liver remnant. J Gastrointest Surg. 2002;6(6):905-913.
11. Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg. 2004;240(4):644-658.
12. Schweizer W, Duda P, Tanner S, et al. Experimental atrophy/hypertrophy complex (AHC) of the liver: portal vein, but not bile duct obstruction, is the main driving force for the development of AHC in the rat. J Hepatol. 1995;23(1):71-78.
13. Krupski G, Broering DC, Wittkugel O, et al. Formation of portal venous collaterals after ligation of the portal vein for induction of liver regeneration [in German]. Rofo. 2002;174(10):1281-1284.
14. Kianmanesh R, Farges O, Abdalla EK, Sauvanet A, Ruszniewski P, Belghiti J. Right portal vein ligation: a new planned two-step all-surgical approach for complete resection of primary gastrointestinal tumors with multiple bilateral liver metastases. J Am Coll Surg. 2003;197(1):164-170.
15. Fernandez FG, Ritter J, Goodwin JW, Linehan DC, Hawkins WG, Strasberg SM. Effect of steatohepatitis associated with irinotecan or oxaliplatin pre-treatment on resectability of hepatic metastases. J Am Coll Surg. 2005;200(6):845-853.
16. Nagino M, Kamiya J, Kanai M, et al. Right trisegment portal vein embolization for biliary tract carcinoma: technique and clinical utility. Surgery. 2000;127(2):155-160.
17. Capussotti L, Muratore A, Ferrero A, Anselmetti GC, Corgnier A, Regge D. Extension of right portal vein embolization to segment IV portal branches. Arch Surg. 2005;140(11):1100-1103.
18. Yamanaka N, Okamoto E, Kawamura E, et al. Dynamics of normal and injured human liver regeneration after hepatectomy as assessed on the basis of computed tomography and liver function. Hepatology. 1993;18(1):79-85.
19. Lee KC, Kinoshita H, Hirohashi K, Kubo S, Iwasa R. Extension of surgical indications for hepatocellular carcinoma by portal vein embolization. World J Surg. 1993;17(1):109-115.
20. Elias D, de Baere T, Roche A, Ducreux M, Leclere J, Lasser P. During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg. 1999;86(6):784-788.
21. Kokudo N, Tada K, Seki M, et al. Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology. 2001;34(2):267-272.
22. Jaeck D, Oussoultzoglou E, Rosso E, Greget M, Weber JC, Bachellier P. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg. 2004;240(6):1037-1051.